The Biomet Pharma group is an international speciality pharmaceutical company selling niche prescription pharmaceuticals. The company markets its products across the globe with primary focus in Asia and EU markets and operational bases in India.


Biomet Pharma is a private company as a result of a public to private Management Buy Out in December 2009. The Group has since refocused as a pure speciality pharmaceuticals provider, having divested all non-pharma business in 2010 and 2011.


Biomet Pharma has a sophisticated product portfolio with particular speciality in the following sections:
Angioedema
Anemia
Arthritis & Anti Inflammatory
Cardiovascular
Hormone Replacement Therapy
Oncology
Biomet Pharma is constantly developing new products and creating new distribution channels.